PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
EBS vs. SMH
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility

Correlation

The correlation between EBS and SMH is 0.32, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.


-0.50.00.51.00.3

Performance

EBS vs. SMH - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Emergent BioSolutions Inc. (EBS) and VanEck Vectors Semiconductor ETF (SMH). The values are adjusted to include any dividend payments, if applicable.

-40.00%-30.00%-20.00%-10.00%0.00%10.00%20.00%SeptemberOctoberNovemberDecember2025February
8.42%
11.53%
EBS
SMH

Key characteristics

Sharpe Ratio

EBS:

3.38

SMH:

0.81

Sortino Ratio

EBS:

3.81

SMH:

1.24

Omega Ratio

EBS:

1.52

SMH:

1.16

Calmar Ratio

EBS:

5.54

SMH:

1.18

Martin Ratio

EBS:

17.34

SMH:

2.77

Ulcer Index

EBS:

31.59%

SMH:

10.60%

Daily Std Dev

EBS:

162.42%

SMH:

36.33%

Max Drawdown

EBS:

-98.89%

SMH:

-83.29%

Current Drawdown

EBS:

-92.08%

SMH:

-13.77%

Returns By Period

In the year-to-date period, EBS achieves a 11.82% return, which is significantly higher than SMH's -0.29% return. Over the past 10 years, EBS has underperformed SMH with an annualized return of -8.05%, while SMH has yielded a comparatively higher 25.99% annualized return.


EBS

YTD

11.82%

1M

3.59%

6M

8.42%

1Y

598.69%

5Y*

-29.74%

10Y*

-8.05%

SMH

YTD

-0.29%

1M

-4.13%

6M

11.53%

1Y

24.41%

5Y*

27.87%

10Y*

25.99%

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

EBS vs. SMH — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

EBS
The Risk-Adjusted Performance Rank of EBS is 9797
Overall Rank
The Sharpe Ratio Rank of EBS is 9898
Sharpe Ratio Rank
The Sortino Ratio Rank of EBS is 9696
Sortino Ratio Rank
The Omega Ratio Rank of EBS is 9595
Omega Ratio Rank
The Calmar Ratio Rank of EBS is 9898
Calmar Ratio Rank
The Martin Ratio Rank of EBS is 9797
Martin Ratio Rank

SMH
The Risk-Adjusted Performance Rank of SMH is 3737
Overall Rank
The Sharpe Ratio Rank of SMH is 3434
Sharpe Ratio Rank
The Sortino Ratio Rank of SMH is 3434
Sortino Ratio Rank
The Omega Ratio Rank of SMH is 3535
Omega Ratio Rank
The Calmar Ratio Rank of SMH is 4848
Calmar Ratio Rank
The Martin Ratio Rank of SMH is 3333
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

EBS vs. SMH - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Emergent BioSolutions Inc. (EBS) and VanEck Vectors Semiconductor ETF (SMH). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


Sharpe ratio
The chart of Sharpe ratio for EBS, currently valued at 3.38, compared to the broader market-2.000.002.004.003.380.81
The chart of Sortino ratio for EBS, currently valued at 3.81, compared to the broader market-4.00-2.000.002.004.003.811.24
The chart of Omega ratio for EBS, currently valued at 1.52, compared to the broader market0.501.001.502.001.521.16
The chart of Calmar ratio for EBS, currently valued at 5.54, compared to the broader market0.002.004.006.005.541.18
The chart of Martin ratio for EBS, currently valued at 17.34, compared to the broader market-10.000.0010.0020.0030.0017.342.77
EBS
SMH

The current EBS Sharpe Ratio is 3.38, which is higher than the SMH Sharpe Ratio of 0.81. The chart below compares the historical Sharpe Ratios of EBS and SMH, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Rolling 12-month Sharpe Ratio0.001.002.003.00SeptemberOctoberNovemberDecember2025February
3.38
0.81
EBS
SMH

Dividends

EBS vs. SMH - Dividend Comparison

EBS has not paid dividends to shareholders, while SMH's dividend yield for the trailing twelve months is around 0.44%.


TTM20242023202220212020201920182017201620152014
EBS
Emergent BioSolutions Inc.
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%5.65%0.00%0.00%
SMH
VanEck Vectors Semiconductor ETF
0.44%0.44%0.60%1.18%0.51%0.69%1.50%1.88%1.43%0.80%2.14%1.16%

Drawdowns

EBS vs. SMH - Drawdown Comparison

The maximum EBS drawdown since its inception was -98.89%, which is greater than SMH's maximum drawdown of -83.29%. Use the drawdown chart below to compare losses from any high point for EBS and SMH. For additional features, visit the drawdowns tool.


-100.00%-80.00%-60.00%-40.00%-20.00%0.00%SeptemberOctoberNovemberDecember2025February
-92.08%
-13.77%
EBS
SMH

Volatility

EBS vs. SMH - Volatility Comparison

Emergent BioSolutions Inc. (EBS) has a higher volatility of 15.33% compared to VanEck Vectors Semiconductor ETF (SMH) at 13.49%. This indicates that EBS's price experiences larger fluctuations and is considered to be riskier than SMH based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


0.00%20.00%40.00%60.00%80.00%SeptemberOctoberNovemberDecember2025February
15.33%
13.49%
EBS
SMH
PortfoliosLab logo
Performance Analysis
Portfolio AnalysisPortfolio PerformanceStock ComparisonSharpe RatioMartin RatioTreynor RatioSortino RatioOmega RatioCalmar RatioSummers Ratio
Community
Discussions


Disclaimer

The information contained herein does not constitute investment advice and made available for educational purposes only. Prices and returns on equities are listed without consideration of fees, commissions, taxes, penalties, or interest payable due to purchasing, holding, or selling.

Copyright © 2025 PortfoliosLab